Whats new

NBRI, CIMAP developed herbal drug for diabetes, 'BGR-34'

DAIBETIES tablet

Two CSIR laboratories in Lucknow, National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plant (CIMAP) jointly developed scientifically validated anti-diabetes herbal drug, named 'BGR-34'.

On the occasion of 62nd annual day of the NBRI on 26 October 2015, this anti-diabetic herbal product was launched for commercial manufacturing and marketing.

The best part of the drug is that it has no side effect and is based on Ayurveda. The drug has extracts from four plants mentioned in Ayurveda and that makes it safe. The drug is for management of type-II diabetes mellitus. The drug has been tested on animals and scientific study has found it safe and effective with clinical trials showing 67% success. The drug boosts immune system, works as antioxidant and checks free radicals. AIR correspondent reports that though there are other anti-diabetic herbal drugs in the market too, BGR-34 has been validated scientifically.

The drug will help maintain normal blood glucose levels, reduce chances of complications due to persistent high blood glucose levels and impart a good quality life to patients with high blood sugar levels.

It was launched earlier by the vice president of India Mohammad Hamid Ansari in February 2014 at Vigyan Bhawan, New Delhi but on October 25, 2105, the product was launched formally. It will be available in the form of tablets and may cost Rs 500 for 100 tablets.